What's new

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive

Mar 12, 2025 - 17:06
 0
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Orphan designation: Seladelpar Treatment of primary biliary cholangitis, 20/02/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: pelabresib monohydrate Treatment of myelofibrosis, 17/02/202...

Next Article

Orphan designation: Magrolimab Treatment of myelodysplastic syndromes, 26/06/202...

Related Posts

Human medicines European public assessment report (EPAR): Pregabalin Pfizer, pregabalin, Date of authorisation: 10/04/2014, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 25, 2025  0

Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Date of authorisation: 18/07/2014, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Medicinal products for human use: monthly figures - Jan...

Feb 25, 2025  0